| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 293 | 2021 |
| Nonadherence in hypertension: how to develop and implement chemical adherence testing D Lane, A Lawson, A Burns, M Azizi, M Burnier, DJL Jones, B Kably, ... Hypertension 79 (1), 12-23, 2022 | 84 | 2022 |
| RADIANCE-HTN investigators. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind … M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... Lancet 397 (10293), 2476-2486, 2021 | 53 | 2021 |
| Antifungal drugs TDM: trends and update B Kably, M Launay, A Derobertmasure, S Lefeuvre, E Dannaoui, ... Therapeutic Drug Monitoring 44 (1), 166-197, 2022 | 52 | 2022 |
| Effects of renal denervation vs sham in resistant hypertension after medication escalation: prespecified analysis at 6 months of the RADIANCE-HTN TRIO randomized clinical trial M Azizi, F Mahfoud, MA Weber, ASP Sharp, RE Schmieder, P Lurz, ... JAMA cardiology 7 (12), 1244-1252, 2022 | 31 | 2022 |
| Belatacept-based immunosuppression: a calcineurin inhibitor-sparing regimen in heart transplant recipients M Launay, J Guitard, R Dorent, Y Prevot, F Prion, L Beaumont, B Kably, ... American Journal of Transplantation 20 (2), 553-563, 2020 | 25 | 2020 |
| Endorsed by the European Society of Hypertension (ESH) Working Group on Cardiovascular Pharmacotherapy and Adherence. Nonadherence in hypertension: how to develop and implement … D Lane, A Lawson, A Burns, M Azizi, M Burnier, DJL Jones, B Kably, ... Hypertension 79 (1), 12-23, 2022 | 15 | 2022 |
| Is there any hope for monitoring adherence in an efficient and feasible way for resistant hypertension diagnosis and follow-up? B Kably, EM Billaud, P Boutouyrie, M Azizi Current Hypertension Reports 22, 1-7, 2020 | 10 | 2020 |
| Urine N-acetyl-Ser-Asp-Lys-Pro measurement as a versatile biomarker to assess adherence to angiotensin-converting enzyme inhibitors B Kably, EM Billaud, A Derobertmasure, A Blanchard, P Boutouyrie, ... Journal of Hypertension 40 (2), 348-355, 2022 | 6 | 2022 |
| Ceftazidime dosing in obese patients: is it time for more? C Fanton D’Andon, P Correia, J Rigaill, B Kably, S Perinel-Ragey, ... Expert Opinion on Drug Metabolism & Toxicology 18 (4), 277-284, 2022 | 5 | 2022 |
| Psychometric Properties of a Machine Learning–Based Patient-Reported Outcome Measure on Medication Adherence: Single-Center, Cross-Sectional, Observational Study V Korb-Savoldelli, Y Tran, G Perrin, J Touchard, J Pastre, A Borowik, ... Journal of Medical Internet Research 25, e42384, 2023 | 3 | 2023 |
| Dried Urine Spot Analysis for assessing cardiovascular drugs exposure applicable in spaceflight conditions A Derobertmasure, B Kably, J Justin, CDS Carvalho, EM Billaud, ... Journal of Chromatography B 1219, 123539, 2023 | 3 | 2023 |
| Nirmatrelvir and ritonavir combination in COVID-19 patients with advanced chronic kidney disease E Lafont, D Blez, MA Bildan, D Veyer, H Péré, J Puech, B Kably, ... Clinical Infectious Diseases 79 (3), 798-800, 2024 | 2 | 2024 |
| Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study L Mimram, S Magréault, Y Kerroumi, D Salmon, B Kably, S Marmor, ... Antibiotics 11 (11), 1462, 2022 | 2 | 2022 |
| What clindamycin dose should be administered by continuous infusion during combination therapy with rifampicin? A prospective population pharmacokinetics study L Mimram, S Magréault, Y Kerroumi, D Salmon, B Kably, S Marmor, ... Journal of Antimicrobial Chemotherapy 78 (12), 2943-2949, 2023 | 1 | 2023 |
| Abstract MP09: Characteristics of Antihypertension Medication Adherence Among Patients with Resistant Hypertension in the RADIANCE HTN-TRIO Ultrasound Renal Denervation Trial M Azizi, A Kirtane, M Bloch, B Kably, J Weil, G Thompson, M McGuire, ... Hypertension 81 (Suppl_1), AMP09-AMP09, 2024 | | 2024 |
| Loading Dose of Ceftazidime Needs to Be Increased in Critically Ill Patients: A Retrospective Study to Evaluate Recommended Loading Dose with Pharmacokinetic Modelling M Launay, E Ollier, B Kably, F Le Louedec, G Thiery, J Lanoiselée, ... Antibiotics 13 (8), 756, 2024 | | 2024 |
| EFFICACY OF ULTRASOUND RENAL DENERVATION BASED UPON CHANGES IN DETECTED ANTIHYPERTENSIVE MEDICATIONS WITHIN THE RADIANCE HTN-TRIO STUDY VJM Zeijen, M Azizi, AJ Kirtane, B Kably, J Daemen Journal of Hypertension 42 (Suppl 1), e264, 2024 | | 2024 |
| Prospective assessment of the frequency of and risk factors for bleeding events in patients treated with cefazolin E Gras, Y Tran, B Kably, A Lillo-Lelouet, T Caruba, B Sabatier, M Launay, ... Infection 52 (2), 557-566, 2024 | | 2024 |
| Evaluating the heart valve tissue diffusion of amoxicillin in infective endocarditis: a pilot prospective observational non-comparative study M Dubert, B Kably, A Derobertmasure, I Podglajen, L Munte, D Clauss, ... Journal of Antimicrobial Chemotherapy 78 (12), 2915-2918, 2023 | | 2023 |
